ロード中...
Retrospective Analysis of Treatment-naive Slovenian Patients with Metastatic Melanoma Treated with Pembrolizumab – Real-world Experience
BACKGROUND: Based on recent data from clinical trials, the immune checkpoint inhibitor pembrolizumab prolongs survival and has a good toxicity profile in patients with advanced or metastatic melanoma. However, the question remains whether these results are transmitted into daily clinical practice. T...
保存先:
| 出版年: | Radiol Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Sciendo
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7087416/ https://ncbi.nlm.nih.gov/pubmed/31955148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2020-0003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|